PR Newswire Clinical TrialsOriginal article
FIRE1 Announces First Patient Implant in the NORM-HF Pivotal Trial Evaluating a New Physiologic Approach to Heart Failure Management
Trial StartPositive
AI Analysis
Summary
FIRE1 announced the first patient implant in the NORM-HF pivotal trial, a randomized international study evaluating whether daily inferior vena cava monitoring and physician-directed patient self-management can reduce worsening heart failure events and cardiovascular mortality.
Clinical Trial Data
Phase
Pivotal
Outcome Details
First patient implant in NORM-HF pivotal trial
Importance:6/10
Sentiment:
0.60
heart failuremedical devicepivotal trialIVC monitoringclinical trial enrollment
Read the original article
Published by PR Newswire Clinical Trials on September 30, 2026 12:30 PM